Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples